Author: SeniorWomenWeb

  • Jerome Powell’s Semiannual Monetary Policy Report; Strong Wage Growth; Inflation, Labor Market, Unemployment, Job Gains, 2 Percent Inflation

    Chair Powell submitted identical remarks to the Committee on Financial Services, U.S. House of Representatives, on March 8, 2023.Reuters pix

    Chairman Brown, Ranking Member Scott, and other members of the Committee, I appreciate the opportunity to present the Federal Reserve’s semiannual Monetary Policy Report.

    Right, Chair Powell;REUTERS/Kevin Lamarque

    My colleagues and I are acutely aware that high inflation is causing significant hardship, and we are strongly committed to returning inflation to our 2 percent goal. Over the past year, we have taken forceful actions to tighten the stance of monetary policy. We have covered a lot of ground, and the full effects of our tightening so far are yet to be felt. Even so, we have more work to do. Our policy actions are guided by our dual mandate to promote maximum employment and stable prices. Without price stability, the economy does not work for anyone. In particular, without price stability, we will not achieve a sustained period of labor market conditions that benefit all.

    I will review the current economic situation before turning to monetary policy.

    Current Economic Situation and Outlook
    The data from January on employment, consumer spending, manufacturing production, and inflation have partly reversed the softening trends that we had seen in the data just a month ago. Some of this reversal likely reflects the unseasonably warm weather in January in much of the country. Still, the breadth of the reversal along with revisions to the previous quarter suggests that inflationary pressures are running higher than expected at the time of our previous Federal Open Market Committee (FOMC) meeting.

    From a broader perspective, inflation has moderated somewhat since the middle of last year but remains well above the FOMC’s longer-run objective of 2 percent. The 12-month change in total personal consumption expenditures (PCE) prices has slowed from its peak of 7 percent in June to 5.4 percent in January as energy prices have declined and supply chain bottlenecks have eased.

    Over the past 12 months, core PCE inflation, which excludes the volatile food and energy prices, was 4.7 percent. As supply chain bottlenecks have eased and tighter policy has restrained demand, inflation in the core goods sector has fallen. And while housing services inflation remains too high, the flattening out in rents evident in recently signed leases points to a deceleration in this component of inflation over the year ahead.

    That said, there is little sign of disinflation thus far in the category of core services excluding housing, which accounts for more than half of core consumer expenditures. To restore price stability, we will need to see lower inflation in this sector, and there will very likely be some softening in labor market conditions. Although nominal wage gains have slowed somewhat in recent months, they remain above what is consistent with 2 percent inflation and current trends in productivity. Strong wage growth is good for workers but only if it is not eroded by inflation.

  • Jo Freeman Reviews: The Trial of Lee Harvey Oswald, A Novel by William Alsup

    The Trial of Lee Harvey OswaldThe Trial of Lee Harvey Oswald, A Novel

    A Novel
    by William Alsup
    Athens, GA: University of Georgia Press, 2022, 320 pages
    Hardcover, $27.95
     
    by Jo Freeman
     
    This book takes the creation of an historical novel to new heights, so much so that “A Novel” is in the subtitle so you won’t mistake it for actual history when looking for books from that period.
     
    History tells us that Lee Harvey Oswald murdered President John F. Kennedy in Dallas, Texas on November 22,1963.  Younger generations may not remember that Oswald was himself shot and killed by Jack Ruby two days later while he was being moved from one jail to another.  He never went on trial. Ruby did.
     
    The fictional assumption in this novel is that Ruby failed, leaving Oswald to be tried in a Texas state court and  …
     
    There are a few other fictional assumptions, and a few fictional characters, which the author explains in the back of the book.  For the most part, the facts and the people are real.  They are based on extensive testimony before the Warren Commission, which was appointed by President Lyndon B. Johnson a week later to investigate Kennedy’s assassination.   It’s 26 volumes of testimony and documents were augmented by press coverage, FBI reports and other archives.
     
    Have fun figuring out who is real and who is not. For example, Oswald’s defense lawyer is Percy Foreman, a Texas trial lawyer who became famous for eloquently defending some very disreputable people.  He had expressed interest in representing Oswald before Ruby killed him.  In Trial he gets the job.
     
    Then there is the Zapruder film, probably the most famous home movie in American history.  Taken by a bystander filming the presidential procession for his personal use, it captured the moments the bullets hit their victims.  It’s analyzed frame by frame.

  • Justice Department Advice About Frauds Targeting Seniors: Identity Theft, Medicare/Medicaid, Lottery/Sweepstakes Fraud, and More

    Editor’s Note: We received a telephone call this morning supposedly from our grandson reporting that he had had a car accident injuring a woman that would incur medical expenses connected to his driving.  This was followed by another call reportedly by a lawyer representing that same woman. Given this personal experience, we thought a Justice Department rundown of similar cases might be helpful just in case you experience the same type of fraud. Being an older grandparent and senior makes one, presumably, more susceptible to these kinds of fraud.

    REPORT FRAUD

    If you are in need of legal advice, please contact your local bar association at www.findlegalhelp.org. The Fraud Section conducts criminal prosecutions and cannot provide legal advice to citizens.

    If you would like to report fraud, please contact the appropriate investigative agency as follows:
     

    Consumer Fraud and Identity Theft
    Contact the Federal Trade Commission at 1-877-FTC-HELP1-877-ID-THEFT, or online at https://ReportFraud.ftc.gov/#/?orgcode=TFMICF.
     

    Disaster-Related Fraud
    Contact the National Center for Disaster Fraud at (8667205721, by fax at (225) 334-4707 or submit a complaint through the NCDF Web Complaint Form.

    Correspondence may be sent to:
    National Center for Disaster Fraud
    Baton Rouge, LA 70821-4909

    General Fraud and Other Criminal Matters
    Contact the FBI at (202) 324-3000, or online at www.fbi.gov or tips.fbi.gov.
     

    Health Care Fraud, Medicare/Medicaid Fraud, and Related Matters
    Contact the Department of Health and Human Services, Office of the Inspector General at 1-800-HHS-TIPS, or online at www.oig.hhs.gov.
     

    Internet Fraud and Lottery/Sweepstakes Fraud by Internet
    Contact the Internet Crime Complaint Center (IC3) online at www.ic3.gov.
     

    Mail Fraud and Lottery/Sweepstakes Fraud
    Contact the U.S. Postal Inspection Service at 1-800-372-8347, or online at postalinspectors.uspis.gov.
     

    Securities Fraud
    Contact the Securities and Exchange Commission at 1-800-SEC-0330, or online at www.sec.gov or www.sec.gov/complaint/select.shtml.

    State and Local Fraud
    Contact your local Police Department or State Attorney General’s Office.

     
     
     
     
  • February’s Hot Data Releases: Governor Christopher J. Waller, Federal Reserve Board Frames a Few of the Issues Around Inflation and the Economic Outlook

    March 02, 2023

    February’s Hot Data Releases

    Governor Christopher J. Waller At the Mid-Size Bank Coalition of America, Los Angeles, California (via webcast)

    Thank you, Raj, and thank you to the coalition for the invitation to be with you — virtually, at least. I don’t want to take up too much of the time for our discussion but let me frame a few of the issues around inflation and the economic outlook.1

    Last month we received a barrage of data that has challenged my view in January that the Federal Open Market Committee (FOMC) was making significant progress in moderating economic activity and reducing inflation. I’m not the only one whose outlook has shifted. Since the end of January, financial market participants have revised their outlooks in a way that has led them to mark up their expectations for the federal funds rate at the end of 2023 by about a half percentage point.

    The shift in the data started with a bang on February 1, with a big increase in the number of job openings in December that reversed the gradual easing over several months in what is a key indicator of tightness in the labor market. Part of the FOMC’s plan to lower inflation is reducing this excess tightness, which has been driving elevated wage growth and contributing to high inflation. The Job Openings and Labor Turnover Survey data can be noisy so, at times, there is a tendency to downplay large moves. But then on February 3, the job report for January showed a stunning 517,000 increase in employment and the unemployment rate moved down to a level not seen in over 50 years.2 These data indicated that, instead of loosening, the labor market was tightening.3 A little over a week later, on Valentine’s Day, instead of a box of chocolates, we got the consumer price index (CPI) inflation report for January and revisions to 2022. By this measure, not only had inflation stopped declining in January, it also slowed a lot less in the second half of last year than previously reported.4 

    Later that week, data on producer prices and last week’s report on personal consumption expenditures (PCE) prices reinforced these two points. Retail sales for January also came in much stronger than expected, suggesting the economy was slowing less than it had appeared just a month earlier, a picture that was confirmed by data on personal spending, which represents almost 70 percent of gross domestic product. Continuing progress on inflation depends on lowering demand and moderating economic activity, and the retail sales and spending data suggest that progress on reducing aggregate demand may have stalled.

  • Welcome to TDI-11861: NIH-funded Team Contraceptive Disables Sperm; More Work is Still Needed Before Human Clinical Trials Could Begin

    About half of all pregnancies worldwide are unintended. Among U.S. adolescents, the rate is even higher. Most modern contraceptive methods are for women. Men generally have two options: condoms or vasectomies.sperm drs

    The challenge with creating new contraceptives for men is the high rate of sperm production. Men produce several million sperm per day — about 1,000 per second. To prevent pregnancy, all of these need to be stopped from reaching an egg.

    Right, Drs. Lonny Levin and Jochen Buck

    Both hormonal and non-hormonal approaches to stop sperm have been in development. But many of these methods need about two months to become effective, and require continuous treatment to remain fully effective. Reversing their effects takes a similarly long time. Thus, there is an unfulfilled need for an on-demand, reversible approach.  

    Following ejaculation, sperm begin to vigorously beat their tails. This enables them to swim through the female reproductive tract and fertilize the egg. An enzyme called soluble adenylyl cyclase (sAC) is needed to trigger this behavior. Male mice engineered to lack sAC are infertile but have few other differences from normal mice. Men who have naturally occurring mutations that inactivate sAC are also infertile.

    An NIH-funded team of researchers, led by Drs. Jochen Buck and Lonny Levin at Weill Cornell Medicine, developed a compound called TDI-11861 that binds and inhibits sAC. They tested its effects on sperm function and fertility. Their findings appeared in Nature Communications on February 14, 2023.

    A variety of tests in mice didn’t identify any potential safety issues with TDI-11861. The team then treated male mice with a single dose of TDI-11861 before allowing them to mate with females. The treated mice showed no differences in mating behavior from untreated mice. But the sperm from treated mice lost the ability to move on their own. Sperm remained immobile after being deposited in the female reproductive tract.

    When male mice treated with TDI-11861 were paired with females, none of the females became pregnant. This contraceptive effect was observed for up to two and a half hours after treatment. In contrast, male mice treated with a control compound impregnated females 30% of the time. The effect of the treatment wore off with time, and by 24 hours after treatment, fertility had recovered completely.

    These findings suggest that an sAC inhibitor could be developed into a safe, temporary contraceptive drug for men. “The team is already working on making sAC inhibitors better suited for use in humans,” Levin says.

    However, more work is still needed before human clinical trials could begin. Several challenges remain before a drug could get approved for people to use.

  • Kaiser Health News and NPR, Surprise-Billing Law Loophole: When ‘Out of Network’ Doesn’t Quite Mean Out of Network

    February 28th, 2023 

    BILL OF THE MONTH

    Danielle Laskey and baby

    Surprise-Billing Law Loophole: When ‘Out of Network’ Doesn’t Quite Mean Out of Network

    Danielle Laskey at her home just outside Seattle, with her infant son. Before giving birth, Laskey experienced a serious pregnancy complication and was admitted for a seven-week hospital stay, plus a follow-up postpartum procedure. It turned out the hospital was out of network for her health plan, and her insurer said surprise-billing laws protecting patients from big out-of-network bills for emergency care did not apply. (RYAN HENRIKSEN FOR KHN)

    It was the first day of her family’s vacation in the San Juan Islands last June when Danielle Laskey, who was 26 weeks pregnant, thought she was leaking amniotic fluid. A registered nurse, Laskey called her OB-GYN back home in Seattle, who said to seek immediate care. Staff members at a nearby emergency department found no leakage. But her OB-GYN still wanted to see her as soon as possible.

    NPR logo

    This story also ran on NPR.

    SUBMIT YOUR BILL

    Laskey and her husband, Jacob, made the three-hour trip to the Swedish Maternal & Fetal Specialty Center-First Hill. Laskey had sought the clinic’s specialized care for this pregnancy, her second, after a dangerous complication with her first: The placenta had become embedded in the uterine muscles.

    Back in Seattle, doctors at the clinic found Laskey’s water had broken early, posing a serious risk to her and the fetus, and ordered her immediate admission to Swedish Medical Center/First Hill. She delivered her son after seven weeks in the hospital. Though she was treated for multiple postpartum complications, she was well enough to be discharged the next day. Her son, who is healthy, went home a month later.

    medical bill

    Laskey soon developed a fever and body aches, and she was told by her OB-GYN to go to Swedish’s emergency department. She said doctors there wanted to admit her when she arrived Aug. 20 and scheduled a procedure for Aug. 26 to remove a fragment of placenta that her body had not eliminated on its own. Laskey, who had already spent weeks away from her 3-year-old daughter, chose to go home. She returned for the procedure, which went well, and she was home the same day. Then the bills came.

    The Patient: Danielle Laskey, 31, was covered by a state-sponsored plan offered by her employer, a local school district, and administered by Regence BlueShield.

    Medical Service: In-patient hospital services for 51 days, plus a one-day stay that included a second placenta removal procedure. Service Provider: Swedish Medical Center/First Hill, part of Providence Health & Services, a large, nonprofit, Catholic health system.

    Total Bill: Swedish, through Regence, billed about $120,000 in cost sharing for Laskey’s initial hospitalization and about $15,000 for her second visit and procedure. What Gives: The specialized clinic caring for Laskey before her hospital admission was in her insurance plan’s network.

  • Kaiser Health News*: May 11th Era of ‘Free’ Covid Vaccines, Test Kits, and Treatments Is Ending. Who Will Pay the Tab Now?

     monkey pox vaccine

    February 10, 2023

    Time is running out for free-to-consumer Covid vaccines, at-home test kits, and even some treatments.

    The White House announced this month that the national public health emergency, first declared in early 2020 in response to the pandemic, is set to expire May 11. When it ends, so will many of the policies designed to combat the virus’s spread.

    Take vaccines. Until now, the federal government has been purchasing covid-19 shots. It recently bought 105 million doses of the Pfizer-BioNTech bivalent booster for about $30.48 a dose, and 66 million doses of Moderna’s version for $26.36 a dose. (These are among the companies that developed the first covid vaccines sold in the United States.)

    People will be able to get these vaccines at low or no cost as long as the government-purchased supplies last. But even before the end date for the public emergency was set, Congress opted not to provide more money to increase the government’s dwindling stockpile. As a result, Pfizer and Moderna were already planning their moves into the commercial market. Both have indicated they will raise prices, somewhere in the range of $110 to $130 per dose, though insurers and government health programs could negotiate lower rates.

    “We see a double-digit billion[-dollar] market opportunity,” investors were told at a JPMorgan conference in San Francisco recently by Ryan Richardson, chief strategy officer for BioNTech. The company expects a gross price — the full price before any discounts — of $110 a dose, which, Richardson said, “is more than justified from a health economics perspective.”

    That could translate to tens of billions of dollars in revenue for the manufacturers, even if uptake of the vaccines is slow. And consumers would foot the bill, either directly or indirectly.

    If half of adults — about the same percentage as those who opt for an annual flu shot — get covid boosters at the new, higher prices, a recent KFF report estimated, insurers, employers, and other payors would shell out $12.4 billion to $14.8 billion. That’s up to nearly twice as much as what it would have cost for every adult in the U.S. to get a bivalent booster at the average price paid by the federal government.

    As for covid treatments, an August blog post by the Department of Health and Human Services’ Administration for Strategic Preparedness and Response noted that government-purchased supplies of the drug Paxlovid are expected to last through midyear before the private sector takes over. The government’s bulk purchase price from manufacturer Pfizer was $530 for a course of treatment, and it isn’t yet known what the companies will charge once government supplies run out.

  • Jo Freeman Reviews: The Moment: Changemakers on Why and How They Joined the Fight for Social Justice

     The Moment: Changemakes onWhy and How They Joined the Fight for Social Justice
     
    Reviewed by Jo Freeman
     
    The Moment: Changemakers on Why and How They Joined the Fight for Social Justice
    By Steve Fiffer
    Athens, GA: University of Georgia Press, xii + 226 pages
    Paperback: $23.95.  Also available as an eBook or audiobook
     
    This book is about acting, not writing.
     
    After publishing his last book in 2021, based on memories and interviews with civil rights icon C.T. Vivian, Fiffer wanted to do more like it.  He felt that many lesser-known people had stories that needed to be told.  His publisher concurred.
     
     It does help to start with an interested publisher.  At that time it was NewSouth books. By the time the book came out in November 2022, NewSouth had become an imprint of the University of Georgia Press.
     
    Fiffer doesn’t tell us how he found his subjects, though many had made the newspapers for what they did.  Some are semi-public figures: Don Katz is the founder of Audible, Inc.  Chokwe Lumumba is Mayor of Jackson, MS. His wife,  Ebony, is an English professor. Renee Montgomery was a WNBA champion.
          
    But not all.
     
    Amirah Ahmed, 18, co-founded Fredericksburg Muslim Youth while a high school student in Virginia.  Ben Shore, who co-founded Rise Against Hate, is a student at American University in DC.  Brian Jon, founded the Asian-American Youth Council while a high school student in New Jersey. He’s now attending college in Pennsylvania.
     
    These are mostly first-person stories, even though they are based on interviews which Fiffer edited into coherent narratives.  Read them like a series of short stories with a common theme.  
     
    This book has an index (right on!) and  its own webpage:  https://www.themoment-thebook.com/  You can order the book there, or go directly to the U. GA press webpage: https://ugapress.org/book/9781588384751/the-moment/ 
     
     Editor’s Note:  Jo has finished her book on working in the civil rights movement and is looking for a publisher.

     
  • Congressional Budget Office: Federal Budget Deficit Totals $1.4 Trillion in 2023; Annual Deficits Average $2.0 Trillion Over the 2024–2033 Period

    CBO image

    • Over the long term, our projections suggest that changes in fiscal policy must be made to address the rising costs of interest and mitigate other adverse consequences of high and rising debt.

    The Budget

    In our latest projections, released on February 16th, the federal budget deficit totals $1.4 trillion in 2023, and annual deficits average $2.0 trillion over the 2024–2033 period. Those projections reflect the assumption that current laws governing federal taxes and spending generally remain unchanged. The deficit amounts to 5.3 percent of GDP in 2023 and grows to 6.9 percent of GDP in 2033 — significantly larger than the 3.6 percent of GDP that deficits have averaged over the past 50 years. (The deficit and spending numbers have been adjusted to exclude the effects of shifts that occur in the timing of certain payments when October 1, the first day of the fiscal year, falls on a weekend.)

    https://www.cbo.gov/about/overview

    The cumulative deficit over the 2023–2032 period that we now project is $3 trillion larger than we projected last May, mainly because of newly enacted legislation and changes to the economic forecast that boost interest costs and spending on mandatory programs.

    Federal debt held by the public is projected to rise from 98 percent of GDP in 2023 to 118 percent in 2033 — an average increase of 2 percentage points per year. Over that period, the growth of interest costs and mandatory spending outpaces the growth of revenues and the economy, driving up debt. Those factors persist beyond 2033, pushing federal debt higher still, to 195 percent of GDP in 2053.

    The increase in mandatory spending is driven by rising costs for Social Security and Medicare. Total discretionary spending falls in relation to GDP. As the cost of financing the nation’s debt grows, net outlays for interest increase substantially.

    After reaching a historic high in 2022, receipts from individual income taxes are projected to fall in 2023 because collections from taxes on capital gains realizations and other sources, which have been strong in recent years, fall in CBO’s projections. Projected receipts rise after 2025 because of the scheduled expiration of certain provisions of the 2017 tax act.

    The Economy

    Now I’ll turn to the economy.

    To reduce high inflation, the Federal Reserve has sharply increased the target range for the federal funds rate over the past year. In our projections, the Federal Reserve further raises the target range for the federal funds rate in early 2023 to reduce inflationary pressures in the economy. That rate falls in 2024 as inflation slows and unemployment rises.

    Inflation is expected to decline in 2023 as pressures ease from factors that, since mid-2020, have caused demand to grow more rapidly than supply. That decline continues until 2027, when the rate of inflation is projected to reach the Federal Reserve’s long-run goal.

    In response to the sharp increase in interest rates that occurred in 2022, the growth of real GDP (that is, GDP adjusted to remove the effects of inflation) comes to a halt in our projections in 2023. As the Federal Reserve reduces the target range for the federal funds rate, real GDP growth rebounds, led by the interest-sensitive sectors of the economy. It averages 2.4 percent from 2024 to 2027 and 1.8 percent from 2028 to 2033.

    The unemployment rate rises through early 2024, reflecting the slowdown in economic growth. That rate falls thereafter, as output returns to its historical relationship with potential output (that is, the maximum sustainable output of the economy).

  • National Institutes of Health: Half of Adults Treated at Hospitals for COVID-19 Experienced Lingering Symptoms, Financial Difficulties, Physical Limitations Months After Discharge

    Many adults experience problems like coughing, chest pain, and fatigue six months after their stay. pavlovid pill

    About half of adults treated at hospitals for COVID-19 have experienced lingering symptoms, financial difficulties, or physical limitations months after being discharged, according to a National Institutes of Health-supported study published in JAMA Network Open.

    After six months, more than 7 in 10 adults surveyed in the study experienced cardiopulmonary problems, such as coughing, rapid or irregular heartbeat, and breathlessness, while about half had fatigue or physical limitations – all symptoms associated with long COVID(link is external). Additionally, more than half of the adults said they faced financial challenges.

    The findings came from the PETAL Network’s Biology and Longitudinal Epidemiology: COVID-19 Observational (BLUE CORAL(link is external)) study, which is supported by the National Heart, Lung, and Blood Institute (NHLBI), part of NIH.

    “My clinic patients often want to know how soon they’ll get back to their usual health,” said Andrew J. Admon, M.D., M.P.H., the study’s first author, a pulmonologist at LTC Charles S. Kettles VA Medical Center, and an assistant professor in the departments of internal medicine and epidemiology at the University of Michigan, Ann Arbor. “Based on these data, it seems that many people hospitalized for COVID-19 should expect symptoms to last for up to six months or even longer.”

    To conduct the analysis, researchers assessed data from the medical records and follow-up surveys of 825 adults who received treatment for COVID at one of 44 medical centers in the United States between August 2020 and July 2021. Patients were surveyed one, three, and six months after leaving the hospital for general or intensive care treatment.

    The researchers found that six months after being hospitalized:

    • Three-fourths of patients, 75%, had at least one cardiopulmonary problem, such as cough or chest problems; swelling in their legs, ankles, and feet; or a need for home oxygen support. This represented an increase from the first month, when 67% of patients reported experiencing problems like these.
    • More than half of patients, 51%, felt fatigued compared to 41% who did so after one month. Almost one in five adults, 18%, felt tired every day
    • More than half of patients, 56%, experienced a financial difficulty such as being unable to pay bills, compared to 66% who had problems after one month. Hispanic and Black participants, as well as participants who reported financial difficulty at one month, were more likely to have experienced financial challenges during the sixth month.
    • Some 47% of patients reported limitations doing everyday activities, such as eating, preparing meals, bathing, getting dressed, or walking across a room, which represented an improvement compared to the first month, when 55% of patients experienced such limitations.
    • Symptoms came and went for some patients, creating intervals of recovery. For instance, some adults were free of symptoms after one month but developed symptoms such as heart and chest problems later.